2022
DOI: 10.1016/j.molstruc.2022.133746
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical novel solid forms of Milrinone with advanced physicochemical properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 40 publications
0
7
0
Order By: Relevance
“…28 Milrinone, olprinone, and their other analogues containing a fragment of 2-oxo-1,2-dihydropyridine-3-carbonitrile are used as cardiotonic drugs for the treatment of heart failure. 29 30 31…”
Section: Table 1 Screening Of Reaction Conditions For T...mentioning
confidence: 99%
See 1 more Smart Citation
“…28 Milrinone, olprinone, and their other analogues containing a fragment of 2-oxo-1,2-dihydropyridine-3-carbonitrile are used as cardiotonic drugs for the treatment of heart failure. 29 30 31…”
Section: Table 1 Screening Of Reaction Conditions For T...mentioning
confidence: 99%
“…28 Milrinone, olprinone, and their other analogues containing a fragment of 2-oxo-1,2-dihydropyridine-3-carbonitrile are used as cardiotonic drugs for the treatment of heart failure. [29][30][31] Known methods for obtaining derivatives of 2-oxonicotinonitrile are based on the substitution of the halogen atom in 2-halonicotinonitriles. For this, sodium hydroxide in an alcoholic or aqueous-alcoholic media 32,33 and acidic solutions can be used as reagents.…”
mentioning
confidence: 99%
“…The crystal structures of MRN, its hydrate form, and HCl salt have been reported. Binary organic salts of this drug were reported with two aliphatic acid coformers, fumaric acid and adipic acid, and five aromatic carboxylic acid coformers, which are nutraceuticals, namely, 2-hydroxybenzoic acid (2HBA), 2,3-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid , syringic acid, and gallic acid. The drug Primacor contains MRN-lactate as the active ingredient and dextrose anhydrous, lactic acid, and sodium hydroxide as excipients.…”
Section: Introductionmentioning
confidence: 99%
“…Many more aspects must be taken into account when switching to a three-component solid. In our prior study, 34 we looked at the generation of binary adducts between 2-HBA and MLN, and hence we presume that the core 2-HBA may function as a possible linker to combine two distinct medications in a dual-drug strategy since 2-HBA forms binary adducts with KTS. In addition, we attempt to investigate any interactions between KTS and MLN, but we end up with a physical mixture (Fig.…”
mentioning
confidence: 99%
“…S6 (ESI †), which reveals that among all the molecular adducts the total contribution of intermolecular interactions involved in KTSÁ2-HBAÁMLN is less than the pure drug KTS. Furthermore, it should be noted that KTSÁ2-HBA (93.2%) and MLN (91.9%) 34 have larger total contact populations than MLNÁ 2-HBA (77.4%), 34 suggesting that this may be one of the factors for the weak dimeric C-HÁÁÁO connection in MLNÁ2-HBA to disintegrate in the tricomponent system while the interactions between MLN and MLN stay intact.…”
mentioning
confidence: 99%